Terms: = Lung cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
325 results:
1. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/erk/STAT3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract] [Full Text] [Related]
2. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target.
Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E
Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
4. Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/p40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
[TBL] [Abstract] [Full Text] [Related]
5. Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Ninomiya H; Sato Y; Inamura K; Dobashi A; Takeuchi K; Mitani H; Mun M; Nishio M; Ishikawa Y
Diagn Pathol; 2024 Feb; 19(1):27. PubMed ID: 38326851
[TBL] [Abstract] [Full Text] [Related]
6. Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer.
Vescio M; Bulloni M; Pelosi G; Pattini L
Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083
[TBL] [Abstract] [Full Text] [Related]
7. The multifaceted roles of COL4A4 in lung adenocarcinoma: An integrated bioinformatics and experimental study.
Zheng T; Zheng Z; Zhou H; Guo Y; Li S
Comput Biol Med; 2024 Mar; 170():107896. PubMed ID: 38217972
[TBL] [Abstract] [Full Text] [Related]
8. FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling.
Liu B; Feng Y; Xie N; Yang Y; Yang D
BMC Cancer; 2024 Jan; 24(1):58. PubMed ID: 38200443
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract] [Full Text] [Related]
10. The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer.
Tian T; Leng Y; Tang B; Dong X; Ren Q; Liang J; Liu T; Liu Y; Feng W; Liu S; Zhou Y; Zhao H; Shen L
Biol Direct; 2024 Jan; 19(1):1. PubMed ID: 38163864
[TBL] [Abstract] [Full Text] [Related]
11. TPI1 promotes MAPK/erk-induced EMT, cell migration and invasion in lung adenocarcinoma.
Li Y; Pan B; Zhang F; Jia X; Zhu X; Tong X; Zhao J; Li C
Thorac Cancer; 2024 Feb; 15(4):327-338. PubMed ID: 38130074
[TBL] [Abstract] [Full Text] [Related]
12. The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature.
Shemesh R; Laufer-Geva S; Gorzalczany Y; Anoze A; Sagi-Eisenberg R; Peled N; Roisman LC
Sci Rep; 2023 Dec; 13(1):21544. PubMed ID: 38057448
[TBL] [Abstract] [Full Text] [Related]
13. DARS2 promotes the occurrence of lung adenocarcinoma via the erk/c-Myc signaling pathway.
Fang T; Jiang J; Yu W; Li R; Tian H
Thorac Cancer; 2023 Dec; 14(36):3511-3521. PubMed ID: 37950542
[TBL] [Abstract] [Full Text] [Related]
14. MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N; Ozawa H; Morimoto Y; Yamashita N; Daimon T; Bhattacharya A; Wang K; Nakashoji A; Isozaki H; Shimokawa M; Kikutake C; Suyama M; Hashinokuchi A; Takada K; Takenaka T; Yoshizumi T; Mitsudomi T; Hata AN; Kufe D
J Thorac Oncol; 2024 Mar; 19(3):434-450. PubMed ID: 37924972
[TBL] [Abstract] [Full Text] [Related]
15. Bronchial oncocytic carcinoma in an adult: a case report and literature review.
Shen YF; Wang CL; Chu ZG; Cao YD; Luo Y; Zhang YL; Cao YJ
BMC Pulm Med; 2023 Oct; 23(1):375. PubMed ID: 37803309
[TBL] [Abstract] [Full Text] [Related]
16. Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer.
Chen HY; Lin CE; Wu SC; Yang ZY; Chiang YF; Huang KC; Wang KL; Ali M; Shieh TM; Chang HY; Huang TC; Hsia SM
Biomed Pharmacother; 2023 Nov; 167():115533. PubMed ID: 37748406
[TBL] [Abstract] [Full Text] [Related]
17. Methylation of KRAS by SETD7 promotes KRAS degradation in non-small cell lung cancer.
Chiang CY; Fan S; Zheng H; Guo W; Zheng Z; Sun Y; Zhong C; Zeng J; Li S; Zhang M; Xiao T; Zheng D
Cell Rep; 2023 Sep; 42(9):113003. PubMed ID: 37682707
[TBL] [Abstract] [Full Text] [Related]
18. The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.
Zhang J; Zhao R; Xu H; Dong L; Chen X
Ann Diagn Pathol; 2023 Dec; 67():152192. PubMed ID: 37639838
[TBL] [Abstract] [Full Text] [Related]
19. N-3, a novel synthetic derivative of bifendate, inhibits metastasis of triple-negative breast cancer via decreasing p38-regulated FOXC1 protein stability.
Wang F; Liao R; Wang X; Xiong G; Zhang B; Li J; Wu D; Chen Y; Zhou X; Gu X; Qi Q; Li C
Biochem Pharmacol; 2023 Sep; 215():115729. PubMed ID: 37558004
[TBL] [Abstract] [Full Text] [Related]
20. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract] [Full Text] [Related]
[Next]
